SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-020471
Filing Date
2019-04-09
Accepted
2019-04-09 16:15:34
Documents
5
Period of Report
2019-04-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7968_18k.htm 8-K 33181
2 EX-3.1 a19-7968_1ex3d1.htm EX-3.1 9510
3 EX-3.2 a19-7968_1ex3d2.htm EX-3.2 123842
4 EX-99.1 a19-7968_1ex99d1.htm EX-99.1 22410
5 GRAPHIC g79681mmi001.jpg GRAPHIC 3239
  Complete submission text file 0001104659-19-020471.txt   194962
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 19739626
SIC: 2834 Pharmaceutical Preparations